Distinguished Professor Anatoly Rozenfeld has been awarded the 2022 NSW Outstanding Cancer Researcher of the Year award.
Director and founder of the University of Wollongong’s Centre for Medical Radiation Physics, Distinguished Professor Rozenfeld is recognised for a 30-year career of discovery and innovation that has brought new treatments to people with cancer.
Career-spanning contributions to best clinical practice
Distinguished Professor Rozenfeld is an internationally recognised leader and researcher in the field of medical dosimetry and a pioneer in the development of semiconductor radiation detectors.
He has published more than 400 peer review research papers and holds 18 patents, with his numerous inventions changing the face of clinical practice in cancer treatment across the globe.
Distinguished Professor Rozenfeld’s career-spanning work has contributed to best clinical practice and offered superior treatment outcomes.
The invention, development and clinical implementation of radiation semiconductor dosimeters has resulted in improved radiation treatments that are more targeted, reducing damage to healthy tissue and providing a better quality of life for people undergoing cancer treatment.
An international leader and pioneer in cancer research
Before emigrating to Australia in the early 1990s, Professor Rozenfeld held engineering and research positions in Radiation Physics at the Institute for Nuclear Research in Kiev, Ukraine, where he also completed his PhD in 1991.
In 1987, he received the USSR Government Commission Honor Award for Research and Development for contributing to the liquidation of consequences at the Chernobyl nuclear plant accident.
As founder of the Centre for Medical Radiation Physics at University of Wollongong, he has secured Australia’s position as a leader in medical radiation physics.
Through his national and international collaborations, he has brought about further opportunities for knowledge exchange and funding. He has been generous with his knowledge and time having guided numerous research students through their studies.
Professor Rozenfeld has delivered more than 100 invited and keynote talks in Australia and overseas, and he has dedicated many years of service to editorial boards, including the International Journal of Instrumentation (JINST, IOP) from 2005 to present, the Physica Medica (European Journal of Medical Physics) between 2007-2013 and has served on the Radiation Measurements editorial board since 2009.
We congratulate Professor Rozenfeld for his positive impact on new treatments for people with cancer, nationally and internationally.
More information about the award
The Outstanding Cancer Researcher of the Year Award recognises an individual researcher who has made an active, outstanding, sustained contribution to any field of cancer research in NSW; has a record of substantive and noteworthy publications; and has supported, developed and mentored cancer researchers.
The successful award recipient receives a prize of $50,000 to assist their research endeavours, and a commemorative award.